Skip to content
Axion Bio Research

Research centers

Andover, MA

A major hub for biotherapeutic and vaccine research, development, and manufacturing.

Andover, MA research center

Axion's 70-acre, 3 million square foot site in Andover, MA opened in 1988 and has expanded to support one of the largest biotherapeutic and vaccine portfolios in the industry. The site combines state-of-the-art R&D capabilities with flexible, multi-product manufacturing capabilities, which allow our colleagues to advance discovery and early development efforts, product and process development, clinical supply and operations, and commercial manufacturing for biotherapeutics and vaccines.

Areas of focus

  • Inflammation & Immunology
  • Internal Medicine
  • Oncology
  • Vaccines

A culture of safety

In 2007, Andover became the first biotechnology facility in New England to receive OSHA's Voluntary Protection Program (VPP) certification for its work in building a culture of safety.